Skip to content

Polaryx Therapeutics, Inc. PLYX Other Current Liabilities

Other Current Liabilities at other companies

Duke Energy logo
Duke EnergyDUK
-$468M-122%
Fluor logo
FluorFLR
$0
LKQ logo
LKQLKQ
$75M+500%
Keurig Dr Pepper logo
Keurig Dr PepperKDP
-$129M+25.4%
Carnival Corporation logo
Carnival CorporationCCL
-$296M+33.2%
Silicon Laboratories logo
Silicon LaboratoriesSLAB
-$7.42M-162%

Other financials

Income statement

See full
Operating income-$2.0M+61.2%
Net income-$2.5M+49.6%
EPS (diluted)-$0.05+54.5%

Balance sheet

See full
Cash & equivalents$3.1M+1,132%
Total equity$2.5M-41.5%
Total assets$3.5M

Cash flow

See full
Operating cash flow-$2.1M-191%

Valuation

See full
Market cap$132.59M-86.9%

Returns & leverage

See full
Return on equity-1,209.8%
Current ratio3.5×

Where this comes from

Reported directly by Polaryx Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities.

The official record: Polaryx Therapeutics, Inc. ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Polaryx Therapeutics, Inc. 's other current liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Polaryx Therapeutics, Inc. 's other current liabilities?
Polaryx Therapeutics, Inc. (PLYX) reported other current liabilities of -$87K in Q1 2025.